Literature DB >> 19867825

PNEUMOCOCCUS HEMOTOXIN.

R Cole1.   

Abstract

Solutions of the bodies of pneumococci, obtained by dissolving them in dilute solutions of sodium cholate, by permitting them to undergo autolysis, or by first freezing, drying, and then grinding in salt solution, are actively hemolytic for rabbit, sheep, guinea pig, and human red blood corpuscles. The substance on which this hemolytic property depends is very labile, much of its activity is lost on passing through a filter, and it is destroyed by the action of trypsin. In its properties it corresponds to the substance contained in such solutions which causes the death of guinea pigs on intravenous injection. Its activity is prevented by the presence of minute amounts of cholesterin. Following the injection of this solution into rabbits and sheep, the sera of these animals acquire increased power of inhibiting its hemolytic action. It therefore possesses antigenic properties. It may therefore be concluded that the bodies of pneumococci contain a toxin that is hemolytic for red blood corpuscles. This substance is not simply a product of autolysis but undoubtedly exists preformed in the bacterial cell. However, it is not given up to the surrounding fluid as long as the bodies of the bacteria are intact. It may therefore be considered a hemolytic endotoxin.

Entities:  

Year:  1914        PMID: 19867825      PMCID: PMC2125211          DOI: 10.1084/jem.20.4.346

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  THE EFFECT OF KILLED BACTERIA ON THE SERUM FERMENTS AND ANTIFERMENT : STUDIES ON FERMENT ACTION. XXVII.

Authors:  J W Jobling; W Petersen; A A Eggstein
Journal:  J Exp Med       Date:  1915-11-01       Impact factor: 14.307

2.  THE PRODUCTION OF METHEMOGLOBIN BY PNEUMOCOCCI.

Authors:  R Cole
Journal:  J Exp Med       Date:  1914-10-01       Impact factor: 14.307

Review 3.  Pneumococcal virulence factors and host immune responses to them.

Authors:  D A Watson; D M Musher; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

4.  THE INFLUENCE OF HEATING THE IMMUNIZATION MATERIAL UPON THE ANTIBODY-INVOKING EFFECTIVENESS OF THE TYPE-SPECIFIC AND SPECIES-SPECIFIC ANTIGENS OF TYPE II PNEUMOCOCCUS CELLS.

Authors:  E L Gaspari; J Y Sugg; W L Fleming; J M Neill
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

5.  THE SERUM FERMENTS AND ANTIFERMENT DURING PNEUMONIA : STUDIES ON FERMENT ACTION. XXIV.

Authors:  J W Jobling; W Petersen; A A Eggstein
Journal:  J Exp Med       Date:  1915-11-01       Impact factor: 14.307

6.  STUDIES ON THE OXIDATION AND REDUCTION OF IMMUNOLOGICAL SUBSTANCES : I. PNEUMOCOCCUS HEMOTOXIN.

Authors:  J M Neill
Journal:  J Exp Med       Date:  1926-07-31       Impact factor: 14.307

Review 7.  Mini-review: novel therapeutic strategies to blunt actions of pneumolysin in the lungs.

Authors:  Rudolf Lucas; Istvan Czikora; Supriya Sridhar; Evgeny Zemskov; Boris Gorshkov; Umapathy Siddaramappa; Aluya Oseghale; Jonathan Lawson; Alexander Verin; Ferenc G Rick; Norman L Block; Helena Pillich; Maritza Romero; Martin Leustik; Andrew V Schally; Trinad Chakraborty
Journal:  Toxins (Basel)       Date:  2013-07-15       Impact factor: 4.546

8.  STUDIES ON OXIDATION AND REDUCTION BY PNEUMOCOCCUS : IV. OXIDATION OF HEMOTOXIN IN STERILE EXTRACTS OF PNEUMOCOCCUS.

Authors:  O T Avery; J M Neill
Journal:  J Exp Med       Date:  1924-04-30       Impact factor: 14.307

9.  STUDIES ON THE OXIDATION AND REDUCTION OF IMMUNOLOGICAL SUBSTANCES : X. IMMUNOLOGICAL DISTINCTIONS BETWEEN THE HEMOTOXIN AND THE "PROTEIN FRACTION" OF THE PNEUMOCOCCUS CELL.

Authors:  J M Neill; W L Fleming; E L Gaspari
Journal:  J Exp Med       Date:  1927-10-31       Impact factor: 14.307

10.  THE METABOLISM OF LUNG TISSUE IN EXPERIMENTAL LOBAR PNEUMOCOCCUS PNEUMONIA IN THE DOG.

Authors:  T E Friedemann; J B Graeser
Journal:  J Exp Med       Date:  1938-02-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.